Some pharmaceutical companies are speculating the Biden administration might announce the maximum fair prices set for the first round of Medicare drug price negotiations at the Democratic National Convention (DNC) next month, ahead of its Sept. 1 deadline to unveil the negotiated prices. The White House deferred to CMS when asked whether officials might unveil the prices during the Aug. 19-22 convention, but industry experts say the possibility should be taken seriously. “I think there are a few ways the...